We noted that the effect of asthma-risk variants on ORMDL3 expression was completely lost when primary naive CD4+ T cells were expanded in culture for a few days (Fig. 2f), suggesting in vitro expansion per se may dampen the effects of the 17q21 variants. The gene discussed is ORMDL3; the disease is asthma.